PANews reported on March 29th that Cathie Wood, founder of Ark Invest, stated in an interview that healthcare is the most undervalued area for artificial intelligence innovation. AI will diagnose cancer before symptoms appear through blood tests; the pharmaceutical industry will face a $300 billion patent cliff in the next five years (meaning that once a patent expires, a company's sales and profits relying on patent protection will plummet), and this fear and caution precisely contains opportunities.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact
crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.